Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder

Biological Psychiatry

Volumn 49, Issue 9, 2001, Pages 741-752

  Rajkowska, Grazyna ^a   Halaris, Angelos ^a   Selemon, Lynn D ^b  

^a Dept Psychiat Hum Behav U   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Frontal cortex; Human; Mood disorders; Morphometry; Postmortem; Schizophrenia

Indexed keywords

ARTICLE; CELL DENSITY; CELL STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GLIA CELL; HUMAN; HUMAN TISSUE; MANIC DEPRESSIVE PSYCHOSIS; MORPHOMETRICS; NERVE CELL; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; THREE DIMENSIONAL IMAGING;

ADULT; AGED; BIPOLAR DISORDER; BRAIN; CELL COUNT; CULTURE TECHNIQUES; FEMALE; HUMANS; HYPERTROPHY; MALE; MIDDLE AGED; NEUROGLIA; PREFRONTAL CORTEX; RETROSPECTIVE STUDIES;

EID: 0035336748     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01080-0     Document Type: Article

References (53)

1. Baron M., Gruen R.S. Schizophrenia and affective disorder Are they genetically linked? Br J Psychiatry. 159:1991;267-270.
2. Baxter L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.M., Selin C.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46:1989;243-250.
3. Benes F.M., Davidson J., Bird E.D. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 43:1986;31-35.
4. Berman K.F., Doran A.R., Pickar D., Weinberger D.R. Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry. 162:1993;183-192.
5. Buchsbaum M.S., Wu J., Delisi L.E., Holcomb H., Kessler R., Johnson J., et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18 F]2-Deoxyglucose in affective illness. J Affect Disord. 10:1986;137-152.
6. Chen G., Zeng W.Z., Yuan P.X., Huang L.D., Jiang Y.M., Zhao Z.H., Manji H.K. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem. 72:1999;879-882.
7. Chen R.W., Chuang D.M. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem. 274:1999;6039-6042.
8. Crow T.J. From Kraepelin to Kretschmer leavened by Schneider The transition from categories of psychosis to dimensions of variation intrinsic to homo sapiens . Arch Gen Psychiatry. 55:1998;502-504.
9. Dupont R.M., Jernigan T.L., Heindel W., Butters N., Shafer K., Wilson T., et al. Magnetic resonance imaging and mood disorders. Arch Gen Psychiatry. 52:1995;747-755.
10. Elkis H., Friedman L., Wise A., Meltzer H.Y. Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Arch Gen Psychiatry. 52:1995;735-746.
11. Figiel G.S., Krishnan K.R., Rao V.P., Doraiswamy M., Ellinwood E.H. Jr, Nemeroff C.B. Subcortical hyperintensities on brain magnetic resonance imaging A comparison of normal and bipolar subjects . J Neuropsychiatry Clin Neurosci. 3:1991;18-22.
12. George MS, Ketter TA, Post RM (1993): SPECT and PET imaging in mood disorders. J Clin Psychiatry 54(Suppl):6-13.
13. Goldberg T.E., Gold J.M., Greenberg R., Griffin S., Schulz S.C., Pickar D., et al. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry. 150:1993;1355-1362.
14. Griffith R., Sutin J. Reactive astrocyte formation in vivo is regulated by noradrenergic axons. J Comp Neurol. 371:1996;362-375.
15. Gundersen H.J.G., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N. The new stereological tools Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis . APMIS. 96:1988;857-881.
16. Harvey I., Persaud R., Ron M.A., Baker G., Murray R.M. Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls. Psychol Med. 24:1994;689-699.
17. Jablensky A (1999): The conflict of the nosologists: Views on schizophrenia and manic-depressive illness in the early part of the 20th century. Schizophr Res 39:95-100; discussion:159.
18. Kato T., Shioiri T., Murashita J., Hamakawa H., Inubushi T., Takahashi S. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Res. 61:1995;151-160.
19. Kato T., Shioiri T., Murashita J., Hamakawa H., Takahashi Y., Inubushi T., Takahashi S. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med. 25:1995;557-566.
20. Khan Z.U., Koulen P., Rubinstein M., Grandy D.K., Goldman-Rakic P.S. An astroglia linked dopamine D2-receptor action in prefrontal cortex. Proc Natl Acad Sci U S A. 98:2001;1964-1969.
21. Kraepelin E (1896): Dementia praecox. In: Cutting J, Shepherd M, editors. The Clinical Roots of the Schizophrenia Concept. Cambridge: Cambridge University Press, 15-24.
22. Kononova IP (1949): Frontal region [in Russian]. In: Sarkissov SA, Filimonoff IN, Preobrazenskaja NS, editors. Cytoarchitectonics of the Human Cerebral Cortex. Moscow: Medgiz, 298-343.
23. Lim K.O., Rosenbloom M.J., Faustman W.O., Sullivan E.V., Pfefferbaum A. Cortical gray matter deficit in patients with bipolar disorder. Schizophr Res. 40:1999;219-227.
24. Manji H.K., Moore G.J., Rajkowska G., Chen G. Neuroplasticity and cellular resilience in mood disorders. Millennium article. Mol Psychiatry. 5:2000;578-593.
25. Moore G.J., Bebchuk J.M., Hasanat K., Chen G., Seraji-Bozorgzad N., Wilds I.B., et al. Lithium increases N-acetyl-aspartate in the human brain In vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry. 48:2000;1-8.
26. Moore G.J., Bebchuk J.M., Wilds I.B., Chen G., Manji H.K. Pharmacologic increase in human gray matter. Lancet. 356:2000;1241-1242.
27. Nasrallah H.A. The continuum of psychoses between schizophrenia and bipolar disorder The neuroanatomical evidence . Neurol Psychiatr Brain Res. 2:1994;206-209.
28. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 95:1998;13290-13295.
29. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry. 48:2000;766-777.
30. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex I. quantitative criteria for distinguishing areas 9 and 46 . Cereb Cortex. 4:1995;307-322.
31. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex II. Variability in locations of areas 9 and 46 . Cereb Cortex. 4:1995;323-337.
32. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 45:1999;1085-1098.
33. Rajkowska G., Selemon L., Goldman-Rakic P. Neuronal and glial somal size in the prefrontal cortex A postmortem morphometric study of schizophrenia and Huntington's disease . Arch Gen Psychiatry. 55:1998;215-224.
34. Rajkowska G., Wei J., Miguel-Hidalgo J.J., Stockmeier C. Glial and neuronal pathology in rostral orbitofrontal cortex in schizophrenic postmortem brain. Schizophr Res. 36:1999;84.
35. Schlaepfer T.E., Harris G.J., Tien A.Y., Peng L.W., Lee S., Federman E.B., et al. Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry. 151:1994;842-848.
36. Selemon L.D., Goldman-Rakic P.S. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci. 5:1985;776-794.
37. Selemon L.D., Lidow M.S., Goldman-Rakic P.S. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol Psychiatry. 46:1999;161-172.
38. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex A morphometric analysis of prefrontal area 9 and occipital area 17 . Arch Gen Psychiatry. 52:1995;805-818.
39. Selemon L.D., Rajkowska G., Goldman-Rakic P. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients Application of a 3-dimensional, stereologic counting method . J Comp Neurol. 392:1998;402-412.
40. Sereno A.B., Holzman P.S. Spatial selective attention in schizophrenic, affective disorder, and normal subjects. Schizophr Res. 20:1996;33-50.
41. Siris S.G. Diagnosis of secondary depression in schizophrenia Implications for DSM-IV . Schizophr Bull. 17:1991;75-98.
42. Spitzer R, Endicott J (1978): Schedule for Affective Disorders and Schizophrenia (SADS), 3rd ed. New York: New York State Psychiatric Institute.
43. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci. 18:1998;7394-7401.
44. Strakowski S.M., Wilson D.R., Tohen M., Woods B.T., Douglass A.W., Stoll A.L. Structural brain abnormalities in first-episode mania. Biol Psychiatry. 33:1993;602-609.
45. Swayze V. II, Andreasen N., Alliger R., Ehrhardt J., Yuh W. Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities. Arch Gen Psychiatry. 47:1990;1054-1059.
46. Taylor M.A., Abrams R. Cognitive impairment patterns in schizophrenia and affective disorder. J Neurol Neurosurg Psychiatry. 50:1987;895-899.
47. Tsacopoulos M., Magistretti P.J. Metabolic coupling between glia and neurons. J Neurosci. 16:1996;877-885.
48. von Economo C (1929): The frontal lobe. In: The Cytoarchitectonics of the Human Cerebral Cortex. London: Oxford University Press, 27-67.
49. Williams R.W., Rakic P. Three-dimensional counting An accurate and direct method to estimate numbers of cells in sectioned material . J Comp Neurol. 278:1988;344-352.
50. Winsberg M.E., Sachs N., Tate D.L., Adalsteinsson E., Spielman D., Ketter T.A. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry. 47:2000;475-481.
51. Wu C., Singh S.K., Dias P., Kumar S., Mann D.M. Activated astrocytes display increased 5-HT2a receptor expression in pathological states. Exp Neurol. 158:1999;529-533.
52. Zihl J., Gron G., Brunnauer A. Cognitive deficits in schizophrenia and affective disorders Evidence for a final common pathway disorder . Acta Psychiatr Scand. 97:1998;351-357.
53. Zipursky R.B., Seeman M.V., Bury A., Langevin R., Wortzman G., Katz R. Deficits in gray matter volume are present in schizophrenia but not bipolar disorder. Schizophrenia Res. 26:1997;85-92.